Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
106 Cards in this Set
- Front
- Back
arachidonic acid derivatives that are derived from phospholipids
|
eicosanoids
|
|
cholesterol derivatives
|
steroids
|
|
function of pituitary gland
|
receives input from hypothalamus and releases appropriate homrones into systemic circulation
|
|
2 major mechanisms for hormone inactivation
|
1- inactivation by enzymes
2- inactivation via removal from receptor area |
|
3 main mechanisms for regulation of hormone synthesis
|
negative control, positive control, feedback inhibition
|
|
tumor formation commonly results in ______ of a particular hormone
|
overproduction
|
|
Autoimmune disorders or genetic defects often cause ______ of a particular hormone
|
underproduction
|
|
Caused by a lack of functional receptors due to genetic defects, autoimmune disorders or overstimulation and downregulation of receptors
|
target cell insensitivity
|
|
AVP/ADH--function?
|
stimulates water reabsorption in principal cells of collecting ducts and constriction of arterioles
|
|
AVP/ADH--origin?
|
posterior pituitary
|
|
Oxytocin--function?
|
stimulates milk ejection from breasts and causes uterine contractions (child birth and copulation)
|
|
Oxytocin--origin?
|
posterior pituitary
|
|
Thyroid stimulating hormone (TSH): origin and function
|
anterior pituitary; stimulates synthesis and secretion of thyroid hormones
|
|
Follicle-stimulating hormone (FSH)
|
anterior pituitary; stimulates sperm maturation in Sertoli cells and follicular development and estrogen syntesis in ovaries.
|
|
Luteinizing hormone (LH)
|
anterior pituitary; stimulates testosterone synthesis in Leydig cells, stimulates ovulation, formation of corpus luteum, estrogen and progesterone synthesis in ovaries
|
|
Growth hormone: origin and function
|
anterior pituitary; stimulates protein synthesis and overall growth
|
|
Prolactin: origin and function
|
anterior pituitary; stimulates milk production and secretion in breast
|
|
Adrenocorticotropic-hormone (ACTH): origin and function
|
anterior pituitary; stimulates synthesis and secretion of adrenal cortical hormones (cortisol, androgens, aldosterone)
|
|
Melanocyte-stimulating hormone (MSH): origin and function
|
anterior pituitary; stimulates melanin synthesis
|
|
Thyrotropin-releasing hormong (TRH): origin and function
|
hypothalamus; simulates secretion of TSH and prolactin
|
|
Corticotropin-releasing hormone (CRH): origin and function
|
hypothalamus; stimulates secretion of ACTH
|
|
Gonadotropin-releasing hormone (GnRH): origin and function
|
hypothalamus; stimulates secretion of FSH and LH
|
|
Somatostatin or Somatotropin release-inhibiting homrone (SRIF): origin and function
|
hypothalamus; inhibits secretion of growth hormone
|
|
Dopamine or Prolactin-ihibiting factor (PIF): origin and function
|
hypothalamus; inhibits secretion of prolactin
|
|
Growth hormone-releasing hormone (GHRH)
|
hypothalamus; stimultes secretion of GH
|
|
Calcitonin
|
thyroid; decreases serum calcium
|
|
increases serum calcium conc
|
parathyroid hormone
|
|
stimulates estrogen and progesterone synthesis in corpus luteum of early pregnancy
|
hCG (human chorinic gonadotropin)
|
|
has GH-like and prolactin-like actions during pregnancy
|
human placental lactogen (hPL) or human chorionic somatomammotropin
|
|
catalyzes conversion of angiotensinogen to angiotensis I
|
renin; released by kidney
|
|
contains a 15-25 residue signal sequence of mostly hydrophobic amino acids at its N-terminus that allows entry into the ER
|
pre-prohormone
|
|
are peptide hormones stored in secretory granules?
|
yes: they are packaged by the TGN into immature secretory granules along with their processing enzymes and other required proteins
|
|
An acidic environment in the immature secretory granules is required for what process?
|
cleavage on carboxy side of paired basic residues of the prohormone (i.e., lysine or arginine)
|
|
What process follows cleavage at paired basic residues?
|
peptide hormones are amidated, which makes them more biologically active and helps preserve their half-life once secreted
|
|
enzyme that amidates prohormones
|
PAM (peptidylGlydie-a-amidating monooxygenase )
|
|
prohormone from which ACTH and beta-LPH are made
|
pro-opiomelanocortin (POMC)
|
|
what is responsible for the differential processing of POMC?
|
enzyme location; conditions (stress, etc.)
|
|
inhibits release of CRH at hypothalamus and release of ACTH at anterior pituitary(via feedback inhibition)
|
cortisol
|
|
inhibits release of ACTH from anterior pituitary via negative inhibition
|
dopamine
|
|
In episodic/circadian secretion, which is secreted first: cortisol or ACTH?
|
ACTH--ACTH causes release of cortisol which then directly inhibits ATCH production and release from the pituitary
|
|
Cushing's Disease or Syndrome: caused by ACTH secreting tumors of pituitary
|
Disease
|
|
Adenoma of adrenal cortex causes release of excess cortisol due to overproduction...what disease?
|
Cushing's Syndrome
|
|
ketoconazole and metyrapone are used to treat what disease?
|
Cushing's Syndrome
|
|
treatment for Cushing's disease?
|
surgical removal o ACTH secreting tumor
|
|
The following symptoms describe what disease: polyuria, polydipsia, dehydration, weakness, mental retardation if not treated
|
Diabetes insipidus
|
|
What type of Diabetes Insipidus is caused by a loss of functionality of AVP receptor in the kidney (usually mutations)
|
Nephrogenic---treat with ibuprofen
|
|
What type of Diabetes Insipidus develops during pregnancy and dissappears 4-6 weeks after delivery?
|
Gestational--treat with desmopressin (synthetic AVP) and time
|
|
What type of Diabetes Insipidus is caused by suppression of vasopressin by excessive intake of fluids?
|
Dipsogenic--treat by decreasing water intake
|
|
What type of Diabetes Insipidus is characterized by a defect int he secretion of AVP from the posterior pituitary, is inherited (via x-linked or autosomal dominant)?
|
Neurogenic--treat with desmopressin (synthetic AVP)
|
|
Enzyme that iodinates thyroglobin
|
thyroidal peroxidase (TPO)
|
|
synthesized in thyroid follicular cells stored as a part of thryoglobin
|
MIT and DIT (monoiodotyrosine and diiodotyrosine)
|
|
where is TPO located?
|
apical border of thyroid acinar cell
|
|
coupling reactions of MIT and DIT form what 2 hormones
|
T3 and T4
|
|
stored in colloidal space where it is iodinated
|
thryoglobulin (TGb)
|
|
what stimulates endocytosis of TGb at apical membrane of acinar cell?
|
binding of TSH to receptor on basal membrane
|
|
What happens in endosomes following endocytosis of TGb?
|
proteases from lysosomes cleave peptide bonds to form T3 and T4 that are released into circulation and MIT and DIT which are recycled
|
|
how are MIT and DIT recycled?
|
deiodinase breaks MIT and DIT down into tyrosine and iodine
|
|
90% T4 and 10% T3 but T3 is more active---why 90/10?
|
major pathway of thyroid metabolism is sequential deiodination, thus 80% of circulating T3 is dervied from T4
|
|
major site of T3 and T4 degradation
|
liver (minor sites are kidney and other tissues)
|
|
thyroid hormones can be conjugated with sulfaces and glucuronides and excreted into bile so that they can undergo what process?
|
enterhepatic circulation
|
|
thyroid hormones are primarily eliminated via what organ
|
kidneys--but some conjugated hormone is eliminated in feces
|
|
T3 and T4 exhibit feedback inhibition...affects secretion of what?
|
TRH, TSH
|
|
What disease: lowered basal metabolic rate, diastolic hypertension, goiter
|
hypothyroidism (insufficient T3/T4)
|
|
What disease: increased metabolic rate, exophthalmos, goiter
|
hyperthyroidism (autoimmune---Anitbodies to TSH receptor)
|
|
Levothyroxine treats what disease?
|
hypothyroidism
|
|
Treatment options for hyperthyroidism
|
surgical resection/ 131-Iodide to destroy the hyperfunctioning cell population
|
|
When thryroid failure results in decreased T3/T4, what is the response of the pituitary?
|
increased secretion of TSH--goiter forms because the only way to keep up/increase production of T3/T4 is to enlarge
|
|
Antibodies to TSH receptor cause its activation and body thinks it needs more T3/T4 even though it may not. What results from this?
|
Goiter--gland increases size to keep up production of T3/T4
|
|
common characteristics of Serotonin, Melatonin and Catecholamines
|
derived from amino acids, small molecules, neurotransmitters
|
|
major elements in response to severe stress
|
catecholamines
|
|
increases HR and SV, dilates pupils, constricts skin and gut arterioles and dilates arterioles in leg muscles, increases blood sugar, increases lipolysis, suppresses immune system
|
epinephrine (and norepinephrine)
|
|
dopamine
|
neurotransmitter as well as hormone that inhibits release of prolactin
|
|
T or F: catecholamines can cross the blood-brain barrier
|
Falso, must be synthesized in CNS...L-DOPA can cross though
|
|
synthesis location of Epi, NE, and Dopamine
|
Epi-adrenal medulla
NE-mainly in sympathetic nerves, also adrenal medulla and CNS Dopamine- CNS |
|
Precursor for all catecholamines
|
Tyrosine
|
|
rate limiting steop for catecholamine synthesis
|
tyrosine hydroxylase, which is activated by a cAMP-dependent protein kinase
|
|
Type of secretion for catecholamines: constituative or regulated
|
regulated (secretory granules)
|
|
2 regulation methods for catecholamines
|
degradation by MAO and re-uptake
|
|
path from tyrosine to epinephrine
|
Tyrosine→DOPA→Dopamine→NE→Epi
|
|
works with MAO to metabolize catetcholamines
|
catechol-O-methyltransferase (COMT)--methylates hydroxyl group
|
|
Disease? : slight male predominance, can be caused by infection, toxins, drugs, association with other neurodegenerative disorders, trauma, metabolic disorders and multiple infarct...present with tremors
|
Parkinson's Disease
|
|
Carbidopa treats what?
|
peripheral decarboxylase inhibitor that treats Parkinson's
|
|
active ingredient of what treatment for Parkinson's is precursor to dopamine?
|
levodopa
|
|
Dopamine agonists used as adjunct to L-Dopa
|
Bromocriptine, Pergolide
|
|
Disease: excess production of catecholamines resultig in hypertension and tachycardia
|
Pheochromocytomas--tumors of adreanal medulla or sympathetic ganglia
|
|
Treatment for Pheochromocytomas
|
surgical resection of tumos, radiation thereapy, chemotherapy
|
|
Plays a role in regulation of mood, sleep, emesis, sexuality and appetite; plays a part in depression, migraines, bipolar disorder, anxiety
|
Serotonin
other roles: liver regeneration, acts as mitogen throughout body, vasocontrictor in blood serum |
|
Melatonin is regulated by dark/light and thus regualtes sleep/wake cycles. When is it released/suppressed?
|
Released during darkness, suppressed by daylight
|
|
What is melatonin used for clinically?
|
inducing sleep, preventing jet lag (works best at times wen it is not being produced in high quanitity)
|
|
Synthesis location of Serotonin and Melatonin
|
Pineal gland
-Serotonin also secreted by small intestine |
|
Precursor to serotonin and melatonin? rate limiting step?
|
Tryptophan; tryptophan hydroxylase
|
|
Enzyme responsible for conversion of N-acetylserotonin to melatonin?
|
hydroxyindol-O-methyl transferase (HIOMT)
|
|
Serotonin and Melatonin: constituative or regulated secretion?
|
regulated
|
|
Degradation of Serotonin/Melatonin
|
both broken down by MAO
5HT removed by transport protein--must be removed for it will continue to elicit response |
|
What Disease: depressed mood caused by chemical imbalance
|
Depression
|
|
Treatment for depression?
|
inhibit MAO or prevent removal of NTs from synaptic cleft--SSRIs: serotonin specific re-uptake inhibitors (fluoxetine and paroxetine)
|
|
generic names for Prozac and Paxil and potentian risks
|
Prozac: Fluoxetine--potential for low birth weight, premature labor and heart defects for fetus
Paxil: Paroxetine--potential for lung defects |
|
What disease? genetic, defective absortption of tryptophan, symptoms include photosensitive dermatitis, intermittent neurological symptoms, and blue diaper syndrome (indicanuria)
|
Hartnup's Disease--autosomal recessive
|
|
Treatment for Hartnup's syndrome?
|
high protein diet with di-peptide tryptophan (di-peptides can be absorbed via di-peptide transporter)
|
|
H-dependent ACh transporter in synaptic vesicles is responsible for what?
|
concentration of ACh
|
|
enzymes that process ACh
|
CHAT--synthesis
AChE--degradation |
|
Degradation of ACh
|
hydrolysis by AChE into choline and acetate--choline is taken up by nerve terminal and ACh is resynthesized by CHAT then concentrated into vesicles
|
|
What disease? symptoms of double vision, ptosis, difficulting swallowing, generalized weakness caused by anitbodies against ACh receptors
|
myasthenia gravis
|
|
Treatment for myastenia gravis?
|
Pyridostigmine--AChE inhibitor
|
|
Organophosphates inhibit AChE resulting in what?
|
hypercholinergic effect due to buildup of ACh in synapses
|
|
Treatment for hypercholingeric effects of chemical exposure?
|
atropine, diazepam, pralidoxime
|